ArticleInternational journal of general medicine2024

Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.